Position in ZTS
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$786,451
-$381,536 QoQ
Shares Held
6,653
-28.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PROFUND ADVISORS LLC holds $17,208,250 across 29 Drug Manufacturers - Specialty & Generic names. ZTS ranks #5 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
4,687 | $2,779,297 | |
| 2 | ALKS |
Alkermes plc.
|
77,769 | $2,749,911 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
17,687 | $2,330,085 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
158,462 | $1,508,558 | |
| 5 | ZTS |
Zoetis Inc.
This page
|
6,653 | $786,451 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
22,305 | $533,758 | |
| 7 | HLN |
Haleon plc
|
50,589 | $506,395 | |
| 8 | VTRS |
Viatris Inc
|
29,453 | $397,910 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $786,451 | 6,653 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $1,167,987 | 9,283 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,125,639 | 7,693 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,225,767 | 7,860 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,397,878 | 8,490 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,399,568 | 8,590 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,866,074 | 9,551 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,705,515 | 9,838 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,794,133 | 10,603 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $2,014,358 | 10,206 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,787,644 | 10,275 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,865,034 | 10,830 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,762,766 | 10,591 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,891,960 | 12,910 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $1,754,567 | 11,832 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $2,168,736 | 12,617 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $2,483,541 | 13,169 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $3,466,934 | 14,207 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $2,683,403 | 13,822 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,691,783 | 14,444 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,321,570 | 14,742 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,657,764 | 16,059 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $2,655,676 | 16,059 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,668,854 | 19,475 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $1,885,864 | 16,024 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||